The U.S. Centers for Disease Control and Prevention's outside expert panel will convene on Tuesday after a nearly two-month delay and expects to review guidelines for several vaccines including ...

(Reuters) -British pharmaceutical giant GSK has not met required ethical and regulatory standards in its marketing and prescription information for its Omjjara drug, an industry self-regulatory body ...

A pill developed by GSK was found to be safe and effective in treating gonorrhea in a late-stage clinical trial, according to ...

A new type of antibiotic for treatment of urinary tract infections in women could also work against gonorrhea infections, a ...

In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target ...

Tim-3, a molecule involved in immune regulation, hinders plaque removal in Alzheimer’s disease. Blocking it in microglia improved brain health in mice, making it a potential treatment target. Tim-3 is ...

Q4 2024 Earnings Call Transcript April 10, 2025 CureVac N.V. misses on earnings expectations. Reported EPS is $-0.16564 EPS, ...

A special congressional committee has recommended a $15 billion investment to boost the United States' biotech advantage over ...

New research reveals that the immune checkpoint molecule Tim-3 plays a critical role in how microglia, the brain’s immune cells, respond to Alzheimer’s disease.

Biotech has been hard hit, as one might expect, leaving many names in bargain territory. Learn why there are opportunities ...

As we previously discussed, beginning in 2022, a series of patent infringement lawsuits were filed against Moderna and ...